Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allergic contact dermatitis after lidocaine/prilocaine cream application
TCTR20260508003Not yet recruiting
- Sponsor
- Strategic Wisdom and Research Institute
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of lidocaine and prilocaine in contact hypersensitivity, sponsored by Strategic Wisdom and Research Institute. Primary endpoint: Incidence of allergic contact dermatitis and irritant contact dermatitis from lidocaine or prilocaine cream among patients with suspected symptoms. Planned start May 2026; status: not yet recruiting.
02
Drugs
lidocaineprilocaine
03
Conditions
contact hypersensitivity
Beyond the preview
Go deeper on TCTR20260508003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260508003.